Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Glycine Ursodeoxycholic Acid
1. Ursodeoxycholylglycine
2. 64480-66-6
3. Glycoursodeoxycholate
4. Gudca
5. Glycylursodeoxycholic Acid
6. Glycine Ursodeoxycholic Acid
7. Pf1g5j2x2a
8. Chembl409348
9. Chebi:89929
10. 2-[[(4r)-4-[(3r,5s,7s,8r,9s,10s,13r,14s,17r)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic Acid
11. N-(3alpha,7beta-dihydroxy-5beta-cholan-24-oyl)-glycine
12. N-[(3alpha,5beta,7beta)-3,7-dihydroxy-24-oxocholan-24-yl]glycine
13. Unii-pf1g5j2x2a
14. Ccris 9498
15. Glycylursodeoxycholate
16. Glycine, N-[(3a,5b,7b)-3,7-dihydroxy-24-oxocholan-24-yl]-
17. Schembl231609
18. 3.alpha.,7.beta.-dihydroxy-5.beta.-cholanoylglycine
19. Gtpl4715
20. Dtxsid20862344
21. Glycine, N-((3.alpha.,5.beta.,7.beta.)-3,7-dihydroxy-24-oxocholan-24-yl)-
22. Amy40653
23. Hy-n1424
24. N-(3.alpha.,7.beta.-dihydroxy-5.beta.-cholan-24-oyl)glycine
25. 3a,7b-dihydroxy-5b-cholanoylglycine
26. Bdbm50375586
27. Lmst05030016
28. Mfcd00137427
29. S6146
30. Zinc13542524
31. Ursodeoxycholylglycine, (+)-
32. Akos027250703
33. Cs-6300
34. As-58487
35. Glycoursodeoxycholic Acid, >=96.0% (tlc)
36. 3alpha,7beta-dihydroxy-5beta-cholanoylglycine
37. 3alpha,7beta-dihydroxy-5beta-cholanoyl Glycine
38. D78413
39. N-(3a,7b-dihydroxy-5b-cholan-24-oyl)glycine
40. A867877
41. Q27077819
42. N-(3alpha,7beta-dihydroxy-5beta-cholan-24-oyl)glycine
43. N-[(3a,5b,7b)-3,7-dihydroxy-24-oxocholan-24-yl]glycine
44. Glycine, N-((3alpha,5beta,7beta)-3,7-dihydroxy-24-oxocholan-24-yl)-
45. N-((3.alpha.,5.beta.,7.beta.)-3,7-dihydroxy-24-oxocholan-24-yl)glycine
| Molecular Weight | 449.6 g/mol |
|---|---|
| Molecular Formula | C26H43NO5 |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 449.31412347 g/mol |
| Monoisotopic Mass | 449.31412347 g/mol |
| Topological Polar Surface Area | 107 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 727 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ANALYTICAL
ABOUT THIS PAGE
A Glycoursodeoxycholic acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glycoursodeoxycholic acid, including repackagers and relabelers. The FDA regulates Glycoursodeoxycholic acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glycoursodeoxycholic acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Glycoursodeoxycholic acid supplier is an individual or a company that provides Glycoursodeoxycholic acid active pharmaceutical ingredient (API) or Glycoursodeoxycholic acid finished formulations upon request. The Glycoursodeoxycholic acid suppliers may include Glycoursodeoxycholic acid API manufacturers, exporters, distributors and traders.
Glycoursodeoxycholic acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glycoursodeoxycholic acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glycoursodeoxycholic acid GMP manufacturer or Glycoursodeoxycholic acid GMP API supplier for your needs.
A Glycoursodeoxycholic acid CoA (Certificate of Analysis) is a formal document that attests to Glycoursodeoxycholic acid's compliance with Glycoursodeoxycholic acid specifications and serves as a tool for batch-level quality control.
Glycoursodeoxycholic acid CoA mostly includes findings from lab analyses of a specific batch. For each Glycoursodeoxycholic acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glycoursodeoxycholic acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Glycoursodeoxycholic acid EP), Glycoursodeoxycholic acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glycoursodeoxycholic acid USP).
LOOKING FOR A SUPPLIER?
